ArticleScientific reports2026
Peptidomics and pharmacological profiling of Odontobuthus doriae (Buthidae) scorpion venom at the kappa opioid receptor.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Scorpion venoms are rich in bioactive peptides, many of which act on ion channels and neurotransmitter systems, yet their capacity to interact with G protein-coupled receptors (GPCRs) has been largely unexplored. Here, we profiled the venom peptides of five species in the family Buthidae and evaluated their activity at the kappa opioid receptor (KOR). Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) revealed species-specific peptide fingerprints in the mass range between 2.5 and 4 kDa, underscoring interspecies peptide toxin variation. Following pre-purification by solid-phase extraction, radioligand displacement assays demonstrated that fractions from Odontobuthus doriae bound to KOR, with Od-e (36% acetonitrile) and Od-f (45% acetonitrile) displacing ~ 35-40% of [³H]-diprenorphine. However, BRET-based functional assays demonstrated only weak receptor activation, suggesting that these peptides may function as partial agonists or antagonists rather than full agonists. Collectively, these findings highlight scorpion venoms as a previously underexplored source of opioid receptor-interacting peptides. Systematic investigation of their structural diversity and pharmacological profiles in the future may not only expand our understanding of venom evolution but also provide novel scaffolds for GPCR ligand discovery and potential analgesic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.